
|Articles|June 14, 2007
A new day in preventing meningococcal disease: Sizing up the available vaccines
The new conjugate vaccine MCV4 promises longer duration of immunity and, perhaps, greater clinical efficacy than the polysaccharide vaccine MPSV4. Questions remain about booster doses, vaccinating young children, and safety.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Redefining type 1 diabetes: Early identification, staging, and clinical implications for pediatric care
2
CDC updates website, opens door for autism and vaccines link
3
FDA approves EYLEA HD injection 8 mg to treat macular edema following RVO and monthly dosing
4
Early genetic testing may reshape care for inherited connective tissue disorders in children
5












